MLTX
MoonLake Immunotherapeutics
NASDAQ · Healthcare · Biotechnology · CH
$11.47
−2.01%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 63.07x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.28x
- Price / sales
- —
- Price / cash flow
- -4.33x
Enterprise value
- Enterprise value
- $540.3M
- EV / sales
- —
- EV / EBITDA
- -2.15x
- EV / EBIT
- -2.01x
- Market cap
- $975.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026